Fox Vision - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 395,650 | 365,760 | 681,892 | 863,454 | 1,352,608 | 1,448,267 | 1,220,867 | 1,311,898 |
| Profit before tax | 59,698 | 76,717 | 213,336 | 213,301 | 352,614 | 380,407 | 429,321 | 426,067 |
| Net profit | 48,644 | 64,975 | 179,580 | 180,311 | 297,615 | 320,867 | 361,390 | 355,431 |
| Equity | 151,781 | 176,756 | 356,336 | 376,646 | 374,261 | 145,128 | 194,576 | 258,617 |
| Liabilities | 46,387 | 58,258 | 74,266 | 148,647 | 190,085 | 138,883 | 100,691 | 121,321 |
| Non-current assets | 11,337 | 10,054 | 7,485 | 4,916 | 4,771 | 2,990 | 1,325 | 33,810 |
| Current assets | 190,733 | 228,554 | 422,707 | 520,270 | 558,298 | 280,846 | 292,993 | 345,376 |
| Total assets | 202,070 | 238,608 | 430,192 | 525,186 | 563,069 | 283,836 | 294,318 | 379,186 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 338,033 | 207,556 | 214,840 |
| Social insurance contributions | - | - | - | - | - | - | 14,935 | 23,852 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -63.8% | -7.6% | +86.4% | +26.6% | +56.7% | +7.1% | -15.7% | +7.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 24.1% | 27.2% | 41.7% | 34.3% | 52.9% | 113.0% | 122.8% | 93.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 32.0% | 36.8% | 50.4% | 47.9% | 79.5% | 221.1% | 185.7% | 137.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 12.3% | 17.8% | 26.3% | 20.9% | 22.0% | 22.2% | 29.6% | 27.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 15.1% | 21.0% | 31.3% | 24.7% | 26.1% | 26.3% | 35.2% | 32.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.3 | 0.2 | 0.4 | 0.5 | 1.0 | 0.5 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 135,650 | 121,920 | 227,297 | 287,818 | 450,869 | 469,713 | 325,565 | 327,975 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Fox Vision - Social security debts
The company had no debts to Sodra
Fox Vision - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Fox Vision, UAB (code 303317197) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €1.31M, up 7.5% year on year, after a weaker 2024 when revenue fell to €1.22M from €1.45M in 2023. Net profit in 2025 reached €355.4K, slightly below the 2024 level of €361.4K but still above the 2023 result of €320.9K. Profitability remained strong, with a 27.1% net profit margin in 2025, following 29.6% in 2024 and 22.2% in 2023. The balance sheet expanded to €379.2K in assets in 2025, compared with €294.3K in 2024 and €283.8K in 2023. Equity increased to €258.6K, while liabilities stood at €121.3K. The company maintained a solid capital structure, supported by an equity ratio of 68.2% and debt-to-equity of 0.47. Asset turnover was 3.46x, and revenue per employee was €328.0K, indicating high operating efficiency. Return measures were very strong in 2025, reflecting the company’s ability to convert its asset base into profit efficiently.